Bayer Ag (adr) Stock News

By Cecilia Butini Bayer AG is selling its environmental science business to private-equity firm Cinven for $2.6 billion, the company said Thursday. The…

Here is how Bayer Aktiengesellschaft (BAYRY) and AllScripts Healthcare (MDRX) have performed compared to their sector so far this year.

Bayer (BAYZF) submitted applications to the U.S. and EU drug regulators seeking approval of Nubeqa (darolutamide) in combination with chemotherapy docetaxel in patients with…

Vivante Health, a Houston, MA-based digital solution for digestive health and disease, raised $16m in Series A funding round. The round was led by 7wireVentures, joined by new investors Human Capital, Intermountain Ventures, SemperVirens, Elements Health Ventures, and Leaps by Bayer and returning investors FCA Venture Partners, NFP Ventures, Lifeforce Capital, and Big Pi Ventures. The company […] The post Vivante Health Raises $16M in Series A Funding appeared first on FinSMEs .

LOS ANGELES, March 8 (Xinhua) -- Los Angeles City Attorney Mike Feuer on Monday announced a lawsuit accusing the agricultural chemical and biotechnology company Monsanto of polluting the city''s waterways and seek payment from the company to clean up the waterways. The lawsuit was filed Friday against three companies that Monsanto spun off in the 1990s: Monsanto Company, now owned by Bayer; Solutia Inc., now owne

Minneapolis, March 08, 2022 (GLOBE NEWSWIRE) -- Today, Tues., March 8, and throughout the month, civic, public, and private buildings and landmarks across the United States are slated to go BLUE (the awareness color for colorectal cancer) in honor of the nation''s colorectal cancer (CRC) community, including over one million colorectal cancer survivors. March is Colorectal Cancer Awareness Month. Minnesota-based Colon Cancer Coalition is leading the effort with help from Fight Colorectal Cancer, and countless volunteers, with the support of sponsors Bayer and Natera. Throughout Colorectal Cancer Awareness Month, over 200 landmarks, health care communities, and private businesses are confirmed to "go blue" with either lights or awareness efforts. The bulk of landmarks are slated to be blue from dusk to dawn on Tues., March 8. In addition, businesses and health care facilities are encouraging employees and patients to wear blue, share information, and encourage screening for the nation''s no. 2 cancer killer.

BAYRY vs. NVO: Which Stock Is the Better Value Option?

Major companies in the pharmaceutical drugs market include Bristol-Myers Squibb, Sanofi S. A, Johnson & Johnson, Novartis AG, Bayer AG, Abbott Laboratories, GlaxosmithKline, AstraZenec, Merck & Co. and CJ Corp. Major companies in the pharmaceutical drugs market include Bristol-Myers Squibb, Sanofi S. A, Johnson & Johnson, Novartis AG, Bayer AG, Abbott Laboratories, GlaxosmithKline, AstraZenec, Merck & Co. and CJ Corp.

Major companies in the oncology drugs market include F. Hoffmann-La Roche Ltd. , Novartis AG, Gilead Sciences Inc. , Bayer AG and Takeda Pharmaceticals. The global oncology drugs market is expected to grow from $199. Major companies in the oncology drugs market include F. Hoffmann-La Roche Ltd. , Novartis AG, Gilead Sciences Inc. , Bayer AG and Takeda Pharmaceticals. The global oncology drugs market is expected to grow from $199.

Major companies in the anti-infective drugs market include Gilead Sciences, GlaxosmithKline, Merck & Co. , Johnson & Johnson, Pfizer Inc. , AbbVie, Bayer AG, Mylan N. V. , Shionogi and F. Hoffmann-La Roche Ltd. Major companies in the anti-infective drugs market include Gilead Sciences, GlaxosmithKline, Merck & Co. , Johnson & Johnson, Pfizer Inc. , AbbVie, Bayer AG, Mylan N. V. , Shionogi and F. Hoffmann-La Roche Ltd.

Bayer officials have announced the company received EPA approval for its newest corn product. Sean Cohen, Bayer Corn Launch Lead, tells IARN that VT4PRO with RNAi Technology will provide U.S. farmers an additional option within the already-strong Bayer corn product portfolio to help control troublesome above-ground and below-ground pests. “We are really excited about this […]

BERLIN (Reuters) – Bayer said on Thursday it is planning to invest over 1.4 billion euros ($1.55 billion) in pharmaceutical production sites in Germany in coming years as part of a future strategy agreed by the management board and works council.

Major players in the gynecology drugs market are Hoffmann-La Roche Ltd. , Pfizer Inc. , Merck & Co. Inc. , Allergan, AstraZeneca, Bayer AG, AbbVie, TherapeuticsMD Inc. , Lupin Pharmaceuticals Inc. and Ferring Holding SA. Major players in the gynecology drugs market are Hoffmann-La Roche Ltd. , Pfizer Inc. , Merck & Co. Inc. , Allergan, AstraZeneca, Bayer AG, AbbVie, TherapeuticsMD Inc. , Lupin Pharmaceuticals Inc. and Ferring Holding SA.

German industrial giant plans to continue maintenance and service operations for now Europe’s largest industrial manufacturing company, Munich-based Siemens said on Wednesday it would suspend its business in Russia following Moscow’s offensive in Ukraine. The company, which produces and services trains and supplies software and industrial equipment, said it would “ put all new business in and international deliveries to Russia on hold ” while it assesses the effects of sanctions imposed on the country by Western states over the past week. Russia accounts for a mere 1% of Siemens’ global sales, but the firm’s train-making unit, Siemens Mobility, has an agreement with Russian Railways to build high-speed Sapsan trains. The current contract for 13 trains is in the works, with the trains scheduled to be produced within two years, while the first brand new Sapsan was delivered to Russia last summer. The order for the trains is worth around $1.22 billion, and the partnership includes a 30-year maintenance contract.